Initially, very promising as an asthma biomarker (8), periostin failed to become a surrogate for sputum eosinophilia (9), but it seems to be a good biomarker for airway remodeling (10, 11) and can differentiate between T2 and non-T2 asthmatics/COPD (12). The gene discussed is POSTN; the disease is asthma.